Prestige Consumer Healthcare Inc.
PBH · NYSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $1,138 | $1,125 | $1,128 | $1,087 |
| % Growth | 1.1% | -0.2% | 3.8% | – |
| Cost of Goods Sold | $503 | $501 | $502 | $466 |
| Gross Profit | $634 | $624 | $625 | $621 |
| % Margin | 55.8% | 55.5% | 55.4% | 57.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $108 | $106 | $107 | $107 |
| SG&A Expenses | $264 | $259 | $252 | $265 |
| Sales & Mktg Exp. | $156 | $153 | $145 | $157 |
| Other Operating Expenses | $34 | $23 | $395 | $26 |
| Operating Expenses | $298 | $282 | $648 | $291 |
| Operating Income | $337 | $342 | -$22 | $330 |
| % Margin | 29.6% | 30.4% | -2% | 30.4% |
| Other Income/Exp. Net | -$53 | -$66 | -$72 | -$67 |
| Pre-Tax Income | $284 | $276 | -$94 | $262 |
| Tax Expense | $70 | $67 | -$12 | $57 |
| Net Income | $215 | $209 | -$82 | $205 |
| % Margin | 18.9% | 18.6% | -7.3% | 18.9% |
| EPS | 4.32 | 4.21 | -1.65 | 4.09 |
| % Growth | 2.6% | 355.2% | -140.3% | – |
| EPS Diluted | 4.29 | 4.17 | -1.65 | 4.04 |
| Weighted Avg Shares Out | 50 | 50 | 50 | 50 |
| Weighted Avg Shares Out Dil | 50 | 50 | 50 | 51 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $48 | $67 | $69 | $64 |
| Depreciation & Amortization | $30 | $31 | $33 | $32 |
| EBITDA | $362 | $374 | $8 | $359 |
| % Margin | 31.8% | 33.2% | 0.7% | 33% |